Thaddeus Allen
About Thaddeus Allen
Thaddeus Allen is the Founder and CEO of Tradewind BioScience, with over 20 years of experience in cancer research and drug development. He has held various academic and industry roles, including positions at UC Berkeley Extension, Cañada College, and Anticancer Bioscience, and has authored 35 publications in the field.
Work at Tradewind BioScience
Thaddeus Allen serves as the Founder and CEO of Tradewind BioScience, a company he established in 2017 in the San Francisco Bay Area. Under his leadership, Tradewind focuses on cancer research and translational therapeutics, emphasizing innovative approaches in drug development. Allen has guided the company through the Y Combinator accelerator program, enhancing its visibility and operational capabilities. He has been at the helm for over six years, driving initiatives that bridge the gap between research and practical applications in cancer therapeutics.
Education and Expertise
Thaddeus Allen holds a Doctor of Philosophy (Ph.D.) in Cellular and Molecular Biology from the University of Toronto, where he studied from 1998 to 2004. He also earned a Master’s Degree in the same field from the University of Toronto, completing his studies from 1996 to 1998. Earlier, he obtained a Bachelor’s Degree in Biology/Pharmacology from McMaster University, studying from 1990 to 1995. His academic background is complemented by extensive experience in both academic and industry settings, particularly in cancer research.
Background
Thaddeus Allen has a diverse professional background, having worked in various roles across multiple institutions. He served as a Research Scientist at the University of California, San Francisco for twelve years, from 2004 to 2016. He also held positions as a Lecturer at UC Berkeley Extension and as Adjunct Faculty at Cañada College in 2018. His experience includes leadership roles in life science start-ups, where he has focused on business development and drug discovery.
Achievements
Thaddeus Allen has authored 35 publications throughout his career, contributing to the field of cancer research. He has more than 20 years of experience in this area, leading drug discovery teams and managing patent portfolios. His training in the laboratory of Nobel Laureate J. Michael Bishop at UCSF has further solidified his expertise. Allen's strong international presence, with work experience in both the United States and China, enhances cross-cultural collaboration in cancer research.